Interleukin-1 expression in normal motor endplates and muscle fibers showing neurogenic changes

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Acta Neuropathologica

• Publication date

  1997-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s004010050703PMID 9292697
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin‐1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes

  1997cited by this paper
• Inflammatory myopathies

  1996cited by this paper
• Cytokine Expression Profile in Idiopathic Inflammatory Myopathies

  1996cited by this paper
• Synthesis and secretion of interleukin-1 alpha and interleukin-1 receptor antagonist during differentiation of cultured keratinocytes.

  1995cited by this paper
• Taxol and colchicine increase LPS-induced pro-IL-1 beta production, but do not increase IL-1 beta secretion. A role for microtubules in the regulation of IL-1 beta production.

  1995cited by this paper
• Modulation of rat vascular smooth muscle cell (VSMC) proliferation by cysteinyl leukotriene D4: a role for mediation of interleukin 1.

  1995cited by this paper
• Synthesis and Secretion of Interleukin-1α and Intedeukin-1 Receptor Antagonist during Differentiation of Cultured Keratinocytes

  1995cited by this paper
• Cytokine expression in the muscle of HIV‐infected patients: Evidence for interleukin‐1α accumulation in mitochondria of AZT fibers

  1994cited by this paper
• An evolutionary perspective on apoptosis.

  1994cited by this paper
• Interleukin-1 receptor antagonist prevents sepsis-induced inhibition of protein synthesis.

  1994cited by this paper
• Regulation of ATP-ubiquitin-dependent proteolysis in muscle wasting.

  1994cited by this paper
• The biological properties of interleukin-1.

  1994cited by this paper
• Effect of tumor necrosis factor or interleukin-1 on muscle amino acid uptake and the role of glucocorticoids.

  1993cited by this paper
• Acute phase response in exercise. III. Neutrophil and IL-1 beta accumulation in skeletal muscle.

  1993cited by this paper
• The Ubiquitin‐Mediated Proteolytic Pathway

  1993cited by this paper
• Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barré syndrome.

  1993cited by this paper
• Prion protein is strongly immunolocalized at the postsynaptic domain of human normal neuromuscular junctions.

  1993cited by this paper
• Strong immunoreactivity of β-amyloid precursor protein, including the β-amyloid protein sequence, at human neuromuscular junctions

  1992cited by this paper
• Changes in plasma cytokines associated with peripheral nerve injury.

  1992cited by this paper
• Strong immunoreactivity of beta-amyloid precursor protein, including the beta-amyloid protein sequence, at human neuromuscular junctions.

  1992cited by this paper
• Immunocytochemical localization of ubiquitin at human neuromuscular junctions

  1992cited by this paper
• Loss and renewal of thick myofilaments in glucocorticoid‐treated rat soleus after denervation and reinnervation

  1992cited by this paper
• Muscle protein breakdown during endotoxemia in rats and after treatment with interleukin-1 receptor antagonist (IL-1ra).

  1992cited by this paper
• Interleukin-1 and thromboxane release after skeletal muscle ischemia and reperfusion

  1992cited by this paper
• Regenerating and denervated human muscle fibers and satellite cells express neural cell adhesion molecule recognized by monoclonal antibodies to natural killer cells

  1992cited by this paper
• Effects of human recombinant interleukin-1 beta on protein synthesis in rat tissues compared with a classical acute-phase reaction induced by turpentine. Rapid response of muscle to interleukin-1 beta.

  1991cited by this paper
• The effect of interleukin-1 alpha and the glucocorticoid receptor blocker RU 38486 on total and myofibrillar protein breakdown in skeletal muscle.

  1991cited by this paper
• Activation of the ubiquitin-ATP-dependent proteolytic system in skeletal muscle during fasting and denervation atrophy.

  1991cited by this paper
• Ubiquitination.

  1991cited by this paper
• Interleukin-1 and interleukin-1 antagonism.

  1991cited by this paper
• Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy.

  1990cited by this paper
• Ultrastructural localization of Interleukin 1 in human peripheral blood monocytes; evidence for IL-1β in mitochondria

  1990cited by this paper
• Expression of various isoforms of neural cell adhesive molecules and their highly polysialylated counterparts in diseased human muscles.

  1990cited by this paper
• The proteasome (multicatalytic protease) is a component of the 1500-kDa proteolytic complex which degrades ubiquitin-conjugated proteins.

  1990cited by this paper
• Increased interleukin 1 beta in human skeletal muscle after exercise.

  1989cited by this paper
• Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1.

  1989cited by this paper
• Increased interleukin 1β in human skeletal muscle after exercise

  1989cited by this paper
• Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells.

  1989cited by this paper
• Immunofluorescent evidence for presence of interleukin-1 in normal and diseased human skeletal muscle.

  1988cited by this paper
• Changes of nerve growth factor synthesis in nonneuronal cells in response to sciatic nerve transection

  1987cited by this paper
• Altered expression of neuronal cell adhesion molecules induced by nerve injury and repair

  1986cited by this paper
• Pathology of Skeletal Muscle

  1984cited by this paper
• Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.

  1984cited by this paper
• Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma.

  1983cited by this paper
• Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (Interleukin-1)

  1983cited by this paper
• Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever.

  1983cited by this paper
• Autophagic degradation in human skeletal muscle target fibers

  1982cited by this paper
• Development and inhibition of the target phenomenon in tenotomized rat muscle.

  1977cited by this paper
• Development and inhibition of the target phenomenon in tenotomized rat muscle

  1977cited by this paper

• Dexamethasone ameliorates recovery process of neuromuscular junctions after tourniquet-induced ischemia-reperfusion injuries in mouse hindlimb.

  2020cites this paper
• Clinical and Genetic Features of Patients with Juvenile Amyotrophic Lateral Sclerosis with Fused in Sarcoma (FUS) Mutation

  2018cites this paper
• iNOS as a Driver of Inflammation and Apoptosis in Mouse Skeletal Muscle after Burn Injury: Possible Involvement of Sirt1 S-Nitrosylation-Mediated Acetylation of p65 NF-κB and p53

  2017cites this paper
• Cachexia – The Interplay Between the Immune System, Brain Control and Metabolism

  2012cites this paper
• Time Course of Changes in Performance and Inflammatory Responses After Acute Plyometric Exercise

  2010cites this paper
• FYN‐dependent muscle–immune interaction after sciatic nerve injury

  2010cites this paper
• Time-course of Changes in Inflammatory and Performance Responses Following a Soccer Game

  2008cites this paper
• EFFECTS OF TWO KINDS OF EXHAUSTIVE MAXIMAL EXERCISE ON PRO-INFLAMMATORY CYTOKINES CONCENTRATIONS IN TRAINED AND UNTRAINED HUMANS

  2005cites this paper
• Regulation of skeletal muscle proteolysis.

  2005cites this paper
• Expression of protein kinase C isoforms and interleukin-1β in myofibrillar myopathy

  2004cites this paper
• Exercise immunology: a skeletal muscle perspective.

  2002cites this paper
• Possible pathogenic mechanisms in inflammatory myopathies.

  2002cites this paper
• Immunological changes in human blood and skeletal muscle in response to physical exercise

  2001influential citation
• IMMUNOLOGICAL CHANGES IN HUMAN BLOOD AND SKELETAL MUSCLE IN RESPONSE TO PHYSICAL EXERCISE

  2001influential citation
• CCR2A and CCR2B, the two isoforms of the monocyte chemoattractant protein-1 receptor are up-regulated and expressed by different cell subsets in idiopathic inflammatory myopathies

  2001cites this paper
• Immunological changes in human skeletal muscle and blood after eccentric exercise and multiple biopsies

  2000influential citation
• Diagnostic Protein Expression in Human Muscle Biopsies

  2000influential citation
• Protease nexin I expression is up‐regulated in human skeletal muscle by injury‐related factors

  1999cites this paper
• Differential expression of the IL-1 system components during in vitro myogenesis: Implication of IL-1β in induction of myogenic cell apoptosis

  1999cites this paper
• Ubiquitin gene expression is increased in human muscle undergoing neurogenic involvement.

  1999cites this paper